SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q2 2022
Institutional positions in SAB Biotherapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +10 vs. Q1 2022
- Shares held
- 3.08M
- +1.29M (+72.3%) vs. Q1 2022
- Total value
- $4.45M
- −$2.27M (−33.8%) vs. Q1 2022
- New holders
- 13
- 9 more added
- Sold out
- 3
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 127 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 167 | $0 | 0.00% | +167 | New |
| Citigroup Inc | 639 | $1.00K | 0.00% | −6,380−90.9% | Reduced |
| Bank of America Corp | 776 | $1.00K | 0.00% | −2,003−72.1% | Reduced |
| UBS Group AG | 1,000 | $1.00K | 0.00% | −407−28.9% | Reduced |
| Rockefeller Capital Management L.P. | 1,200 | $1.00K | 0.00% | +100+9.1% | Added |
| JPMorgan Chase & Co | 1,808 | $3.00K | 0.00% | −3,192−63.8% | Reduced |
| Advisor Group Holdings, Inc. | 2,213 | $3.00K | 0.00% | +883+66.4% | Added |
| Wolverine Asset Management LLC | 3,926 | $5.00K | 0.00% | −2,500−38.9% | Reduced |
| Spectrum Management Group, LLC | 5,030 | $7.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4,820 | $7.00K | 0.00% | 00.0% | Unchanged |
| Penserra Capital Management LLC | 6,405 | $9.00K | 0.00% | +2,681+72.0% | Added |
| Tower Research Capital LLC (TRC) | 8,176 | $12.0K | 0.00% | +6,445+372.3% | Added |
| 1st Source Bank | 10,000 | $15.0K | 0.00% | +10,000 | New |
| Kestra Advisory Services, LLC | 11,000 | $16.0K | 0.00% | +11,000 | New |
| Elgethun Capital Management | 13,296 | $18.0K | 0.01% | +13,296 | New |
| ETF Managers Group, LLC | 13,581 | $19.0K | 0.00% | +394+3.0% | Added |
| Goldman Sachs Group Inc | 14,462 | $21.0K | 0.00% | −1,032−6.7% | Reduced |
| Charles Schwab Investment Management Inc | 16,238 | $24.0K | 0.00% | +16,238 | New |
| Brookstone Capital Management | 19,618 | $24.0K | 0.00% | +19,618 | New |
| AE Wealth Management LLC | 18,700 | $27.0K | 0.00% | +18,700 | New |
| LGL Partners, LLC | 23,000 | $33.0K | 0.01% | +23,000 | New |
| Morgan Stanley | 24,752 | $36.0K | 0.00% | −212−0.8% | Reduced |
| Veritable, L.P. | 43,551 | $63.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 44,476 | $64.0K | 0.00% | 00.0% | Unchanged |
| Silver Oak Securities, Inc | 51,941 | $64.0K | 0.01% | +51,941 | New |
| Creative Planning | 46,528 | $67.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 64,220 | $93.0K | 0.00% | +64,220 | New |
| Institutional & Family Asset Management, LLC | 78,115 | $113.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $118.0K | 0.00% | +38,900+91.9% | Added |
| Bridgeway Capital Management, LLC | 84,000 | $122.0K | 0.00% | +84,000 | New |
| BlackRock Inc. | 127,446 | $185.0K | 0.00% | +54,928+75.7% | Added |
| Shaolin Capital Management LLC | 275,000 | $399.0K | 0.01% | 00.0% | Unchanged |
| Meteora Capital, LLC | 292,538 | $424.0K | 0.08% | +292,538 | New |
| Geode Capital Management, LLC | 316,663 | $459.0K | 0.00% | +15,553+5.2% | Added |
| First PREMIER Bank | 652,440 | $946.0K | 0.28% | +652,440 | New |
| Vanguard Group Inc | 721,651 | $1.05M | 0.00% | +500+0.1% | Added |
| Alps Advisors Inc | 0 | $0 | 0.00% | −45,083−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −24,179−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −250−100.0% | Sold out |